Featured Firms
Presented by BigVoodoo
Johnson & Johnson has once again agreed to buy heart device maker Guidant Corp., but for about $21.5 billion -- $4 billion less than it offered 11 months ago. The J&J and Guidant boards have both approved the revised agreement, which must be ratified by Guidant shareholders. The FTC conditionally approved the deal earlier this month, but has required J&J to sell off certain rights and assets related to drug-eluting stents, endoscopic vessel harvesting products and anastomotic assist devices.
November 16, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
At NJM, a top-rated insurance company, we are seeking an Attorney on our Workers Compensation legal team with between 3 and 5 years of expe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS